Opportunity Information: Apply for PAR 24 316
The NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed), funding opportunity number PAR-24-316, is a National Institutes of Health (NIH) career development grant run through the National Cancer Institute (NCI). Its main purpose is to strengthen and broaden the cancer research workforce by supporting scientists from diverse backgrounds, with particular emphasis on individuals from groups that are nationally underrepresented in the biomedical, behavioral, social, and clinical sciences. In practical terms, the program is meant to increase diversity of perspectives and approaches in NCI-funded cancer research by giving promising investigators the time, mentorship, and resources to become more competitive and independent as researchers.
The award is structured as a mentored research scientist development mechanism, meaning it is not simply a research project grant. Instead, it pays for a sustained period of "protected time" so the awardee can focus heavily on career development activities, intensive research training, and building a strong publication and funding track record under the guidance of an experienced mentor (and, if needed, co-mentors). Alongside salary support, the FOA also provides research support intended to help the candidate carry out the proposed research and training plan in a way that accelerates their progression toward research independence in cancer-related fields.
A key boundary in this specific FOA is the clinical trial limitation. This version is intended for applicants whose proposed work does not involve leading an independent clinical trial, a clinical trial feasibility study, or serving as the lead investigator on an ancillary study tied to a clinical trial. However, it still allows candidates to gain clinical trial-related experience as part of their development, as long as the trial itself is led by the mentor or co-mentor. If an applicant plans to lead a clinical trial or lead an ancillary clinical trial study, they are directed to apply to the companion FOA designed for that purpose rather than this "independent clinical trial not allowed" announcement.
Eligibility on the applicant organization side is broad and includes many types of U.S.-based entities that commonly apply for NIH grants. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; and a range of nonprofit organizations (both with and without 501(c)(3) status), as well as for-profit organizations (other than small businesses) and small businesses. The FOA also highlights additional institution types that are often closely aligned with the diversity mission, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, the announcement is explicit about foreign involvement restrictions. Non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by NIH policy) are not allowed under this FOA. In other words, the applicant organization and the supported activities need to remain within the allowable U.S. organizational and project component boundaries described by NIH.
From an administrative standpoint, this is a discretionary grant opportunity in the Education and Health activity area, associated with CFDA number 93.398. The opportunity was created on November 18, 2024, and lists an original closing date of January 7, 2028. The source information provided does not specify an award ceiling or the expected number of awards, so applicants typically need to consult the full FOA text and NIH guidance for budget structure, allowable costs, project period details, and any institute-specific funding priorities or pay plan considerations.
Overall, PAR-24-316 is designed for early-career or developing investigators who need mentored time and support to solidify a cancer research trajectory, with a strong emphasis on enhancing workforce diversity and ensuring that recipients can devote concentrated effort to research and professional development without the added responsibility of leading an independent clinical trial during the award period.Apply for PAR 24 316
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
- This funding opportunity was created on 2024-11-18.
- Applicants must submit their applications by 2028-01-07.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): NCI Mentored Research Scientist Development Award to Promote Diversity (K01, Independent Clinical Trial Not Allowed) - PAR-24-316
What is PAR-24-316?
PAR-24-316 is the NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed). It is an NIH career development (K-series) funding opportunity administered through the National Cancer Institute (NCI).
What is the main goal of this K01 award?
The main goal is to strengthen and broaden the cancer research workforce by supporting scientists from diverse backgrounds, with particular emphasis on individuals from groups that are nationally underrepresented in the biomedical, behavioral, social, and clinical sciences. In practice, it aims to increase diversity of perspectives and approaches in NCI-funded cancer research by helping promising investigators become more competitive and independent.
Is this award a standard research project grant?
No. This is a mentored research scientist development mechanism rather than a standalone research project grant. It is designed to provide a sustained period of protected time for career development, intensive research training, and mentored research under the guidance of an experienced mentor (and, if needed, co-mentors).
What does "protected time" mean in the context of this opportunity?
Protected time refers to dedicated time supported by the award so the candidate can focus heavily on career development activities and research training, build a publication record, and strengthen competitiveness for future funding and research independence, rather than being pulled primarily into other duties.
What types of support does the FOA provide?
The FOA provides salary support and research support intended to help the candidate carry out the proposed research and training plan. The overall intent is to accelerate progression toward research independence in cancer-related fields.
Who is this opportunity intended to support?
This opportunity is designed for early-career or developing investigators who need mentored time and support to solidify a cancer research trajectory, particularly investigators from diverse backgrounds and individuals from groups nationally underrepresented in relevant scientific disciplines.
What is the clinical trial rule for PAR-24-316?
This FOA is for applicants whose proposed work does not involve leading an independent clinical trial, a clinical trial feasibility study, or serving as the lead investigator on an ancillary study tied to a clinical trial.
Are clinical trial-related activities allowed at all under this FOA?
Yes. The FOA allows candidates to gain clinical trial-related experience as part of their development, as long as the clinical trial itself is led by the mentor or co-mentor. The key restriction is that the K01 candidate cannot be the lead investigator for an independent clinical trial or specified clinical trial leadership activities under this announcement.
What should an applicant do if they plan to lead a clinical trial or lead an ancillary clinical trial study?
If an applicant intends to lead an independent clinical trial or lead an ancillary clinical trial study, they are directed to apply to the companion FOA designed for that purpose rather than this "Independent Clinical Trial Not Allowed" announcement.
What is the role of the mentor in this award?
The award is explicitly mentored. The candidate is expected to work under the guidance of an experienced mentor, and co-mentors may be included if needed, to support the candidate's research training and career development toward independence.
What kinds of organizations are eligible to apply?
Eligibility on the applicant organization side is broad and includes many U.S.-based entities commonly eligible for NIH grants. Examples listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and tribal organizations that are not federally recognized.
Are nonprofits eligible to apply?
Yes. The FOA includes nonprofit organizations with 501(c)(3) status and nonprofit organizations without 501(c)(3) status among eligible applicants.
Are for-profit organizations eligible to apply?
Yes. The FOA lists for-profit organizations (other than small businesses) and also lists small businesses as eligible applicant organizations.
Are public housing authorities eligible to apply?
Yes. Public housing authorities/Indian housing authorities are included among the eligible applicant organizations.
Are minority-serving institutions specifically mentioned?
Yes. The FOA highlights institution types often aligned with the diversity mission, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations among eligible applicant organization types.
Are U.S. territories or possessions eligible to apply?
Yes. The FOA includes U.S. territories or possessions among eligible applicants.
Can a non-U.S. (foreign) organization apply?
No. Non-domestic (non-U.S.) entities are not eligible to apply under this FOA.
Can a U.S. organization apply if the project includes a non-domestic component?
No. Non-domestic components of U.S. organizations are not eligible to apply under this FOA.
Are foreign components allowed in the project?
No. Foreign components (as defined by NIH policy) are not allowed under this FOA. The applicant organization and supported activities must remain within the allowable U.S. organizational and project component boundaries described by NIH.
Which federal agency is offering this opportunity?
The opportunity is offered through the National Institutes of Health (NIH) and run through the National Cancer Institute (NCI).
What is the activity area or grant type classification?
The opportunity is described as a discretionary grant opportunity in the Education and Health activity area.
What is the CFDA number associated with this opportunity?
The CFDA number associated with this opportunity is 93.398.
When was this opportunity created?
The opportunity was created on November 18, 2024.
What is the original closing date listed for this opportunity?
The source information lists an original closing date of January 7, 2028.
Does the provided information specify an award ceiling or expected number of awards?
No. The provided source information does not specify an award ceiling or the expected number of awards.
Where should applicants look for budget structure, allowable costs, and project period details?
Because the provided information does not include budget and award volume details, applicants typically need to consult the full FOA text and NIH guidance for budget structure, allowable costs, project period details, and any institute-specific funding priorities or pay plan considerations.
What is the overarching focus area for the supported research and development?
The overall focus is cancer-related research, paired with structured career development and mentored training to help the candidate move toward research independence.
Why does the FOA emphasize diversity?
The FOA emphasizes diversity to broaden the cancer research workforce and increase diversity of perspectives and approaches in NCI-funded cancer research, with particular emphasis on supporting individuals from groups nationally underrepresented in relevant scientific disciplines.
Browse more opportunities from the same category: Education, Health
Next opportunity: NEA Challenge America, FY 2026
Previous opportunity: AMBASSADORS FUND FOR CULTURAL PRESERVATION(AFCP) 2025
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 24 316
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 24 316) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Apply for PAR 25 204 Funding Number: PAR 25 204 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) Apply for PAR 25 152 Funding Number: PAR 25 152 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 25 244 Funding Number: PAR 25 244 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Apply for PAR 25 243 Funding Number: PAR 25 243 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) Apply for PAR 25 229 Funding Number: PAR 25 229 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) Apply for PAR 25 228 Funding Number: PAR 25 228 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 25 096 Funding Number: PAR 25 096 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 25 095 Funding Number: PAR 25 095 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| NCMRR Early Career Research Award (R03 Clinical Trial Optional) Apply for PAR 25 124 Funding Number: PAR 25 124 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Apply for PAR 25 070 Funding Number: PAR 25 070 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Apply for PAR 25 069 Funding Number: PAR 25 069 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Apply for RFA HG 25 003 Funding Number: RFA HG 25 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 25 275 Funding Number: PAR 25 275 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Apply for RFA HG 25 002 Funding Number: RFA HG 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 25 129 Funding Number: PAR 25 129 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 25 128 Funding Number: PAR 25 128 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) Apply for RFA DA 26 034 Funding Number: RFA DA 26 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) Apply for PAR 25 135 Funding Number: PAR 25 135 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 25 083 Funding Number: PAR 25 083 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 25 186 Funding Number: PAR 25 186 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 24 316", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.